Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
In Vivo ; 22(3): 397-400, 2008.
Article in English | MEDLINE | ID: mdl-18610754

ABSTRACT

BACKGROUND: Lymphocytopenia represents one of the most evident side-effects of radiotherapy (RT), particularly in the case of irradiation of pelvis, since it is the main location of bone-marrow proliferating cells in adults. Because of the fundamental role of lymphocytes in suppressing anticancer immunity, RT-induced lymphocytopenia could negatively influence the prognosis of cancer patients and the therapeutic efficacy of RT itself. In experimental conditions, the biological toxicity of irradiation appeared to be reduced by antioxidant agents, such as pineal hormones melatonin. A preliminary study was conducted to evaluate the influence of different immunobiological strategies with pineal indoles melatonin (MLT), 5 methoxytriptamine (5-MTT) or low-dose IL-2, the lymphocyte growth factor, on pelvic irradiation-induced lymphocytopenia in cancer patients suffering from rectal cancer or uterine cervix carcinoma. PATIENTS AND METHODS: The study included 20 consecutive patients, who underwent pelvic irradiation for a total dose of 50.4 Gy. The patients were randomized to be concomitantly treated with MLT alone, with MLT plus 5-MTT or with s.c. low-dose IL-2 . RESULTS: RT induced a significant decline in the mean number of lymphocytes while neither MLT alone, nor MLT plus 5-MTT were able to significantly reduce this decline. Conversely, IL-2 caused a statistically significant reduction of the RT-induced effect, so that the mean number of lymphocytes was significantly higher in patients concomitantly treated by IL-2 than in the other groups. CONCLUSION: This preliminary study showed that low-dose IL-2 was sufficient to reduce, even though not to completely abrogate, RT-induced lymphocytopenia. Further studies with different schedules and doses of IL-2 will be required to optimize the protective effect of IL-2 on irradiation-induced lymphocytopenia in humans.


Subject(s)
Endocrine System/immunology , Immunologic Factors/pharmacology , Indoles/pharmacology , Interleukin-2/pharmacology , Lymphopenia/immunology , Lymphopenia/prevention & control , Rectal Neoplasms/radiotherapy , Uterine Neoplasms/radiotherapy , Adult , Aged , Female , Humans , Lymphocyte Count , Lymphopenia/metabolism , Lymphopenia/pathology , Male , Middle Aged , Pineal Gland/chemistry , Rectal Neoplasms/immunology , Uterine Neoplasms/immunology
2.
In Vivo ; 21(4): 647-50, 2007.
Article in English | MEDLINE | ID: mdl-17708360

ABSTRACT

BACKGROUND: Cancer progression depend on the immune and endocrine status of the patients. In particular, it has been observed that abnormally high levels of cortisol and/or an altered circadian secretion are associated with a poor prognosis in advanced cancer patients. The present study was performed to establish whether cancer-induced hypercortisolemia depends on an activation of the hypothalamic-pituitary axis or on a direct adrenal stimulation by inflammatory cytokines, such as IL-6, which have been proven to induce cortisol secretion. PATIENTS AND METHODS: The study included 50 metastatic solid tumor patients, who were evaluated before the onset of chemotherapy. Venous blood samples were collected in the morning to measure IL-10, IL-6, ACTH and cortisol serum levels. Moreover, to analyze its circadian secretion, cortisol levels were also evaluated on venous blood samples collected at 4.00 p.m. RESULTS: Abnormally high morning levels of cortisol were observed in 19/50 (38%) patients. Moreover, a lack of a normal circadian rhythm of cortisol was seen in 8/50 (16%) patients. None of the patients showed high levels of ACTH. Abnormally high concentrations of IL-6 and IL-10 were present in 21/50 (42%) and in 14/50 (28%) patients, respectively. Mean serum levels of both IL-6 and IL-10 were significantly higher in patients with hypercortisolemia than in those with normal cortisol values (p<0.005 and p<0.001, respectively). According to previous clinical studies, these results confirm that the advanced neoplastic disease may be associated with enhanced cortisol levels and alterations of its circadian secretion. The lack of enhanced ACTH secretion excludes the possibility that the abnormal cortisol production is due to the activation of the hypothalamic-pituitary axis. On the contrary, the evidence of significantly higher concentrations of IL-6 in hypercortisolemic patients would suggest that cancer-related enhanced cortisol production may depend on a direct adrenal stimulation by IL-6 itself The well-demonstrated stimulatory role of cortisol on IL-10 production would explain the enhanced IL-10 secretion in hypercortisolemic patients. CONCLUSION: Cancer-related hypercortisolemia would seem to depend on alterations of the feedback mechanisms between endocrine and cytokine secretions, occurring in the neoplastic disease.


Subject(s)
Cushing Syndrome/immunology , Cushing Syndrome/physiopathology , Hypothalamo-Hypophyseal System/immunology , Hypothalamo-Hypophyseal System/physiopathology , Neoplasms/immunology , Neoplasms/physiopathology , Adrenocorticotropic Hormone/blood , Adult , Aged , Breast Neoplasms/immunology , Breast Neoplasms/pathology , Breast Neoplasms/physiopathology , Carcinoma, Non-Small-Cell Lung/immunology , Carcinoma, Non-Small-Cell Lung/physiopathology , Carcinoma, Non-Small-Cell Lung/secondary , Circadian Rhythm/immunology , Colorectal Neoplasms/immunology , Colorectal Neoplasms/pathology , Colorectal Neoplasms/physiopathology , Female , Humans , Hydrocortisone/blood , Interleukin-10/blood , Interleukin-6/blood , Lung Neoplasms/immunology , Lung Neoplasms/pathology , Lung Neoplasms/physiopathology , Male , Middle Aged , T-Lymphocytes, Regulatory/immunology
3.
J Biol Regul Homeost Agents ; 20(1-2): 29-35, 2006.
Article in English | MEDLINE | ID: mdl-18088552

ABSTRACT

The recent advances in the investigation of tumor immunobiology have suggested that cancer chemotherapy, in addition to its well known cytotoxic activity, may play modulatory effects on the endogenous production of cytokines involved in the control of both tumor angiogenesis and antitumor immunity. Cancer chemotherapy constantly acts with inhibitory effects on anti-bacterial, anti-viral and anti- mycotic immune responses, whereas its action on anticancer immunity, which is mainly mediated by lymphocytes, has still to be better investigated and defined. The present study was carried out to evaluate the influence of chemotherapy on lymphocyte count and its relation to the clinical response in cancer patients suffering from the most commonly frequent tumor histotypes, including lung, colorectal, breast and prostate carcinomas. The study included 144 consecutive metastatic solid tumor patients. Lung cancer patients were treated with cisplatin plus gemcitabine, colorectal cancer patients received oxaliplatin plus 5-fluorouracil, while those affected by breast cancer or prostate carcinoma were treated with taxotere alone. An objective tumor regression was achieved in 66 out of 144 (46 percent) patients, whereas the remaining 78 patients had only a stable disease (SD)or a progressive disease. Independently of tumor histotype and chemotherapeutic regimen, a lymphocytosis occurred in patients who achieved an objective tumor regression in response to chemotherapy, and lymphocyte mean count observed at the end of the chemotherapeutic treatment was significantly higher with respect to the values seen before the onset of treatment. On the contrary, lymphocyte mean number decreased on chemotherapy in patients with SD or PD, even though the decline was statistically significant with respect to the pretreatment values in the only patients who had a PD in response to chemotherapy. This study would suggest that chemotherapy itself may paradoxically act, at least in part, as a cancer immunotherapy by inducing lymphocytosis, as well as previously demonstrated for the only immunotherapy with IL-2, probably by modulating the cytokine network and correcting the altered endogenous production of cytokines, responsible for cancer-related immunodeficiency.


Subject(s)
Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Lymphocytosis/chemically induced , Neoplasms/drug therapy , Adult , Aged , Female , Humans , Lymphocyte Count , Lymphocytosis/pathology , Male , Medical Oncology , Middle Aged , Neoplasm Staging , Neoplasms/pathology
4.
In Vivo ; 19(6): 1077-80, 2005.
Article in English | MEDLINE | ID: mdl-16277025

ABSTRACT

The present study was carried out to evaluate the influence of a short-period IL-2 administration on the efficacy of chemotherapy in metastatic colorectal cancer patients with pretreatment lymphocytopenia, which was defined as a lymphocyte count of less than 1500/mm3. The study included 144 consecutive metastatic colorectal cancer patients, who underwent chemotherapy with oxaliplatin plus 5-fluorouracil. Lymphocytopenia was seen in 41/144 (28%) patients, who were randomized to receive chemotherapy alone or chemotherapy after a prechemoimmunotherapy with IL-2 (3 MIU twice/day for 3 consecutive days), whereas patients with a normal pretreatment lymphocyte count received only chemotherapy. A normalization of the lymphocyte number was achieved in 12/19 lymphocytopenic patients pretreated with IL-2. The objective tumor regression rate achieved in patients with a normal lymphocyte count prior to chemotherapy was significantly higher compared to that obtained in lmphocytopenic patients treated with chemotherapy alone (54/103 vs. 3/22, p < 0.01), whereas no significant difference occurred between patients with normal lymphocyte count and lymphocytopenic patients pretreated with IL-2 (54/103 vs. 8/19). This study confirms that pretreatment lymphocytopenia is associated with reduced efficacy of chemotherapy in metastatic colorectal cancer patients. Moreover, it suggests that pretreatment with IL-2 before the onset of chemotherapy may enhance the efficacy of chemotherapy in lymphocytopenic patients. Therefore, the administration of IL-2 before the onset of chemotherapy to improve the immune status of cancer patients may be considered as a new chemoimmunotherapeutic combination, which may be recommended in the treatment of advanced cancer patients, particularly in those with cancer-related immune alterations.


Subject(s)
Antimetabolites, Antineoplastic/therapeutic use , Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols , Interleukin-2/therapeutic use , Lymphopenia/drug therapy , Adult , Aged , Antimetabolites, Antineoplastic/administration & dosage , Antineoplastic Agents/administration & dosage , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/pathology , Colorectal Neoplasms/therapy , Female , Fluorouracil/administration & dosage , Fluorouracil/therapeutic use , Humans , Injections, Subcutaneous , Interleukin-2/administration & dosage , Lymphocyte Count , Lymphocytes/metabolism , Male , Middle Aged , Neoplasm Metastasis/drug therapy , Neoplasm Metastasis/pathology , Neoplasm Metastasis/therapy , Organoplatinum Compounds/administration & dosage , Organoplatinum Compounds/therapeutic use , Oxaliplatin , Time Factors , Treatment Outcome
6.
Minerva Psichiatr ; 33(1): 57-65, 1992.
Article in Italian | MEDLINE | ID: mdl-1406162

ABSTRACT

Giuseppe R. Brera's B-test was used in a group of students from upper secondary school (102 male adolescents and 86 females) in order to carry out a preliminary standardisation in centiles and to assess the pattern of the seven scales of the test: mood, anxiety, interpersonal affectivity, sociability, autonomy of ego, strength of ego and guilt in adolescents. Factorial analysis by multiple correspondence was used in the same group of adolescents, with the exception of a subgroup of 20 14-year-old students from lower secondary school. The latter was carried out to assess the efficacy of the test in identifying groups of adolescents using the standard association of positive or negative methods of presenting the 44 variables and the free replies to the questions: what do you dream about, what do you look at, what do you advise. Standardisation in centiles allowed indicative risk scores for mental health to be defined for each factor, with the exception of the anxiety factor in males which appears to be a relatively widespread phenomenon in adolescent. Fewer adolescent females suffer from problems of depression, anxiety, interpersonal affectivity and sociability, whereas adolescent males present a smaller number of problems related to the autonomy of the ego, the strength of the ego and guilt. In line with previous works, the test identified 26% of adolescent males and 23% of adolescent females suffering from various in terms of the mean scores from the different factors. For the first time to our knowledge, multiple correspondence analysis identified nine groups of adolescents distributed along two factorial axes: 1 = mood, 2 = interpersonal affectivity. Groups 1 and 2 were characterized by being contrary to the other negative methods.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Projective Techniques/standards , Psychology, Adolescent , Semantic Differential/standards , Adolescent , Female , Humans , Male
8.
Minerva Psichiatr ; 24(1): 19-24, 1983.
Article in Italian | MEDLINE | ID: mdl-6621300

ABSTRACT

PIP: The English language and Scandinavian literatuare include an ample discussion of the problem of negative psychological and psychiatric sequelae of abortion. However, most works are based on an epistemologically incorrect methodology, being limited to a statistical comparison of the absence and presence of sequelae. The present study is based on a specially prepared clinical evaluation scale, investigating 11 women, 18 months after abortion, all with negative psychological sequelae. In 6 women, psychiatric sequelae were encountered. A considerable incidence of depression and profound emotional disturbance was evident. A clinical comparison using the same scale between the sequelae 20 days and 18 months after abortion revealed increased disturbance in 7 women. It is emphasized that the psychological sequelae following a hospital abortion should be considered iatrogenic and a direct result of the introduction of hospital abortions, a barbarous bloodletting indicative of the self-destructive dominance of technology and ideology. (author's modified)^ieng


Subject(s)
Abortion, Legal/adverse effects , Mental Disorders/etiology , Female , Humans , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...